Queensland LNP Government Axes $1 Billion Wind Farm Project
Queensland Deputy Premier Jarrod Bleijie has cancelled a $1 billion (US$650 million) wind farm project in his state citing lack of community support.
The Liberal National Party (LNP) government brought the curtain down on the Moonlight Range Wind Farm on May 26 a project located 40 kilometres north-west of the central city of Rockhampton.
The state government said it received 550 submissions during a public consultation process on the project, with 85 percent calling for its application to be reviewed.
Deputy Premier Bleijie's decision comes amid
'Queenslanders deserve to have a say on any major development in their local community, which is why our government introduced new nation-leading laws to give them a voice on issues that impact the future of their towns,' he said in a statement.
'Today's announcement highlights how these laws are already helping to level the playing field by ensuring councils and communities have a seat at the decision-making table.
Related Stories
2/2/2025
11/2/2024
'For too long Queensland communities were ignored by Labor's failed laws, which shut them out of the approvals process for renewable energy projects proposed to be built in their backyard.'
Deputy Premier Jarrod Bleijie (L) and Premier David Crisafulli arrive to talk to media after being sworn in at Government House in Brisbane, Australia, on Oct. 28, 2024.
AAP Image/Jono Searle
Liberal National MP Glen Kelly, whose Mirani electorate includes the project site, said the decision was great news for locals.
'Today is a great day for the Mirani electorate,'
'I've stood shoulder to shoulder with our communities from the start, raising serious concerns about the lack of consultation and the completely inappropriate location of this project.'
Moonlight Range's cancellation comes three months after the
The government has also introduced new rules and requirements for any approval, effectively making it more challenging for wind turbine developments to receive the green light.
The Moonlight Range Wind Farm Project
The proposed Moonlight Range included plans for up to 88 wind turbines and a battery energy storage system.
It was estimated that the project would cover a total area of 1,269 hectares, including 434 hectares of vegetation.
However, Kelly has claimed that Moonlight Range would need 741 hectares of native vegetation to be cleared and for mountain tops to be blasted flat to install the turbines.
According to project developer
The company estimated that the project would create around 300 jobs during peak construction and employ up to 10 permanent full-time staff upon completion.
Photo of land clearing and preparation for the Clarke Creek wind farm in central Queensland, Australia.
Courtesy of Steven Nowakowski
A Mixed Signal to the Clean Energy Sector: Environmental Group
The Queensland Conservation Council (QCC), an environmental advocacy organisation, said the axing of the Moonlight Range Wind Farm sent a mixed signal to the sector.
'Queensland's ageing coal power stations were offline a staggering 78 times over the last summer period,' QCC senior campaigner
'We simply cannot afford to rely on these unreliable generators that drive up power prices when they break down.
'The message from the electorate at the federal election was crystal clear: Australians support renewable energy and climate action.'
The Epoch Times has reached out to Queensland Energy Minister David Janetzki and Greenleaf Renewables for additional comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
SINOVAC Board of Directors Prevails Against Advantech/Prime's New York Lawsuit
BEIJING--(BUSINESS WIRE)--SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today announced it has prevailed against Advantech/Prime Success' ('Advantech/Prime') Petition for Emergency Injunctive Relief in the U.S. District Court for the Southern District of New York. The result in the New York court represents another failure in the campaign by Advantech/Prime in coordination with Vivo Capital (together known as the 'Dissenting Investor Group') to wrest control of SINOVAC from its recently installed, lawfully-elected Board of Directors (the 'current SINOVAC Board') in accordance with the Privy Council order and Antiguan Law, and to interfere with the payment of the US$55.00 per common share special cash dividend declared by the current SINOVAC Board. Following the New York court's ruling, the current SINOVAC Board is free to pursue its legal action in Antigua seeking to cancel the PIPE shares invalidly issued to the Dissenting Investor Group by the former illegitimate board (the 'Imposter Former Board'). If the current SINOVAC Board succeeds in legal proceedings on the PIPE shares, it has announced its intention to redistribute an additional US$11.00 per common share to SINOVAC's valid shareholders. Dr. Chiang Li, Chairman of the SINOVAC Board, commented, 'We will continue our mission to restore fairness and deliver value to all valid SINOVAC shareholders, starting with paying the $55.00 per share special cash dividend as soon as July 7, 2025.' The Dissenting Investor Group's self-serving, multi-pronged lawfare strategy against SINOVAC has one goal: to prevent all valid SINOVAC common shareholders from receiving any dividend payments unless the Dissenting Investor Group receives an allocation for their invalid PIPE shares, despite the fact that they have already received over US$1 billion in dividends from a SINOVAC operating subsidiary. The current SINOVAC Board has set aside in escrow the pro rata portion of dividends for the PIPE shares — funds the Dissenting Investor Group could receive if the legal proceedings they initiated rule in their favor. The current SINOVAC Board is fighting back – and winning. We feel certain that we will prevail against any further legal action by the Dissenting Investor Group and look forward to ensuring all valid shareholders receive their fair share. Your Vote is Important Your vote on or before July 8 will be about the future of SINOVAC, your receipt of your make-whole dividend payments in the near-term, and the long-term value of your investment. We urge you to keep SINOVAC's Board in place and vote on the WHITE proxy card ' AGAINST ' Proposal 1 to remove the current Board and ' AGAINST ' Proposal 2 to appoint the Reconstituted Imposter Board Slate. Your vote is critical to ensuring that SINOVAC remains on the path to stability, growth, and value creation for all shareholders. DISCARD any items you received asking you to vote for the Reconstituted Imposter Former Board Slate. If you have already voted for the Reconstituted Imposter Former Board Slate, you can subsequently revoke it by using the WHITE proxy card or WHITE voting instruction form to vote. Only your latest-dated vote will count! If you have questions about how your vote can be counted, please contact our proxy solicitor, Georgeson LLC, toll free at (844) 568-1506 in the U.S. and (646) 543-1968 outside the U.S. or via email at SinovacSpecialMeeting@ About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Important Additional Information and Where to Find It In connection with SINOVAC's Special Meeting, SINOVAC has filed with the U.S. Securities and Exchange Commission ('SEC') and mailed to shareholders of record entitled to vote at the Special Meeting a definitive proxy statement and other documents, including a WHITE proxy card. SHAREHOLDERS ARE ENCOURAGED TO READ THE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS WHEN FILED WITH THE SEC AND WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and other interested parties will be able to obtain the documents free of charge at the SEC's website, or from SINOVAC at its website: You may also obtain copies of SINOVAC's definitive proxy statement and other documents, free of charge, by contacting SINOVAC's Investor Relations Department at ir@ Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
Yahoo
3 hours ago
- Yahoo
Building a $28,000 TFSA Portfolio One Contribution at a Time
Written by Adam Othman at The Motley Fool Canada Ever since central banks in the US and Canada started cutting key interest rates, economic activity has picked up pace in both countries. While the rate cuts are currently paused amid trade and geopolitical tensions, analysts predict two more rate cuts of 25 basis points as inflation and tariff-related headwinds ease. Lower interest rates also mean you cannot generate too much interest income from cash held in high-interest savings accounts. If you have $28,000 of contribution room available in a Tax-Free Savings Account (TFSA), I can tell you a much better way of generating good monthly returns. The TSX has no shortage of monthly dividend-paying stocks. Building a portfolio of high-quality TSX stocks paying monthly distributions to shareholders can be a great way to generate extra monthly income. Here's a table giving you a quick look at how a hypothetical amount of around $28,000 across three such TSX stocks can deliver $144 in monthly dividends in a TFSA without incurring taxes. After that, you can read a bit about each. Ticker Recent Price Number of Shares Amount Invested Monthly Dividends Per Share Total Monthly Payout Per Stock PZA $14.91 625 $9,318.75 $0.0775 $48.44 SIA $18.52 503 $9,315.56 $0.078 $39.23 $25.37 368 $9,336.16 $0.1542 $56.75 Total Monthly Payout $144.42 Pizza Pizza Royalty Corp. (TSX:PZA) is a $497.3 million market-cap company that owns and franchises quick-service restaurants under several brands, boasting almost 800 restaurants from one coast to the other. The monthly dividend-paying stock generates revenue by collecting royalties from its franchisees based on how much they sell, making its cash flows less vulnerable to wage increases or commodity price fluctuations, which weigh on many businesses in the industry. The brands under the company's banner consistently keep adding value to end consumers by updating menus and using creative brand messaging. The company is also planning to continue to increase its locations. I believe this stock can be a good investment for earning relatively safe monthly dividends. Sienna Senior Living Inc. (TSX:SIA) is a $1.7 billion market-cap giant in the senior living space. It is among the largest owners of senior housing facilities in Ontario, servicing the aging population. Occupancy rates are getting higher and higher, and it generates revenue from several business segments catering to different markets within Canada. As long as the growth in the senior population continues, so will the demand for the services that SIA stock offers. The company ended the first quarter of fiscal 2025 with $445 million in liquidity, indicating that it has more than enough capital to fund monthly dividends and acquire more facilities under its banner. It can be another solid investment to consider for monthly dividends. SmartCentres REIT (TSX: is a Real Estate Investment Trust (REIT) that can help you earn monthly income like a lazy landlord. If you have the cash outlay for stock market investing, you have the ability to invest in the real estate sector, all without the hassle of being an actual landlord. has a portfolio of almost 200 properties in key locations across the country, with over 95% of its tenants having a regional or national presence. Most of its revenue comes from commercial tenants offering essential services, giving it solid cash-generating opportunities. Boasting an impressive 98.4% occupancy rate, it can be a solid investment. I feel that you should take any opportunity you can to make more money, and the TFSA gives you the perfect chance to do that. The tax-sheltered nature of the account means you can enjoy the returns from your investments in the account without incurring taxes. The table at the start paints a picture of what the monthly income might look like with a hypothetical $28,000 across three monthly dividend stocks. Add capital gains in the long term into the mix and your total returns over a few years can be much higher. The post Building a $28,000 TFSA Portfolio One Contribution at a Time appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends SmartCentres Real Estate Investment Trust. The Motley Fool has a disclosure policy. 2025
Yahoo
9 hours ago
- Yahoo
TSX Penny Stocks With Market Caps Under CA$200M
As we head into the second half of 2025, the Canadian market is navigating a landscape shaped by ongoing tariff and trade negotiations, which could influence economic growth and inflation. Despite these uncertainties, the potential for positive economic growth remains, especially as both Canada and the U.S. are largely service-driven economies. In this context, penny stocks—often representing smaller or newer companies—continue to be an intriguing investment area due to their potential for significant returns when backed by strong financial health. Name Share Price Market Cap Financial Health Rating PetroTal (TSX:TAL) CA$0.69 CA$640.24M ★★★★★☆ Orezone Gold (TSX:ORE) CA$1.24 CA$665.6M ★★★★★☆ Dynacor Group (TSX:DNG) CA$4.40 CA$189.71M ★★★★★★ Findev (TSXV:FDI) CA$0.445 CA$12.6M ★★★★★★ Thor Explorations (TSXV:THX) CA$0.77 CA$518.93M ★★★★★★ Automotive Finco (TSXV:AFCC.H) CA$0.89 CA$17.44M ★★★★★★ NTG Clarity Networks (TSXV:NCI) CA$2.26 CA$98.22M ★★★★★★ Intermap Technologies (TSX:IMP) CA$2.19 CA$125.23M ★★★★★☆ Hemisphere Energy (TSXV:HME) CA$1.95 CA$185.99M ★★★★★★ McChip Resources (TSXV:MCS) CA$1.00 CA$5.65M ★★★★★★ Click here to see the full list of 890 stocks from our TSX Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Psyched Wellness Ltd. is a health supplements company that produces and distributes mushroom-derived products and related consumer packaged goods in the United States, with a market cap of CA$8.66 million. Operations: The company generates revenue from its Vitamins & Nutrition Products segment, amounting to CA$0.64 million. Market Cap: CA$8.66M Psyched Wellness Ltd. is a pre-revenue company with CA$0.64 million in sales, facing auditor concerns about its ability to continue as a going concern. Despite having no debt and sufficient short-term assets (CA$6.7M) to cover liabilities (CA$234.9K), it remains unprofitable with increasing losses over the past five years at 14.7% annually. The stock's volatility is high, yet stable compared to previous periods, and shareholders have not faced significant dilution recently. A recent pilot for a new dietary supplement may offer future revenue potential if successful in consumer testing and market launch preparations are completed effectively. Unlock comprehensive insights into our analysis of Psyched Wellness stock in this financial health report. Review our historical performance report to gain insights into Psyched Wellness' track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Sailfish Royalty Corp. focuses on acquiring precious metals royalty and streaming agreements, with a market cap of CA$185.49 million. Operations: The company generates revenue of $3.07 million from its royalties and stream interests. Market Cap: CA$185.49M Sailfish Royalty Corp. has a market cap of CA$185.49 million and is not pre-revenue, with US$0.59 million in revenue for Q1 2025 despite a net loss of US$0.075 million compared to the previous year's profit. The company benefits from its 2% net smelter return royalty on Mako Mining's El Golfo area, where promising drill results have been reported, potentially enhancing future cash flows and resource expansion opportunities. While Sailfish's earnings grew significantly last year, its forecasted decline in earnings presents a challenge alongside limited interest coverage by EBIT and dividends not well covered by earnings or free cash flow. Click here to discover the nuances of Sailfish Royalty with our detailed analytical financial health report. Understand Sailfish Royalty's earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: NeoTerrex Minerals Inc. is involved in the evaluation, acquisition, and exploration of mineral properties in Canada with a market cap of CA$14.96 million. Operations: NeoTerrex Minerals Inc. does not currently report any revenue segments. Market Cap: CA$14.96M NeoTerrex Minerals Inc., with a market cap of CA$14.96 million, is pre-revenue and focuses on mineral exploration in Canada. The company has no debt and maintains a cash runway exceeding one year under stable conditions. Recent announcements highlight fully-funded exploration plans targeting rare earth elements across several projects, including Mount Discovery and Galactic REE projects, leveraging favorable tax incentives. Despite its unprofitability, NeoTerrex's strategic focus on critical minerals positions it for potential future value creation pending successful exploration outcomes. However, the stock remains highly volatile with significant price fluctuations observed recently. Navigate through the intricacies of NeoTerrex Minerals with our comprehensive balance sheet health report here. Explore historical data to track NeoTerrex Minerals' performance over time in our past results report. Click through to start exploring the rest of the 887 TSX Penny Stocks now. Ready To Venture Into Other Investment Styles? AI is about to change healthcare. These 22 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include CNSX:PSYC TSXV:FISH and TSXV:NTX. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
